| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |